Back to 
Jacobs Levy Equity Management, Inc.
Jacobs Levy Equity Management, Inc.
SGMOQ
17 quarters
Position history for Jacobs Levy Equity Management, Inc.'s holdings in SANGAMO THERAPEUTICS, INC
As of its Q1 2026 13F, Jacobs Levy Equity Management held 2,050,384 shares of SGMOQ (Sangamo Therapeutics), worth $506,240. Jacobs Levy Equity Management's 13F filings listed SGMOQ from Q2 2022 to Q1 2026, 16 quarterly filings.
Final Value
$0
Final Shares
0
Total Value Change
-$410,000
Total Shares Change
-99,010
Quarter-by-Quarter History
Other major holders of SGMOQ: Wasatch Advisors LP, State Street Corp., Wellington Management Group LLP